Terms: = Breast cancer AND IHC4 AND Diagnosis
5 results:
1. Clinical validation of an immunohistochemistry-based CanAssist-breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients.
Bakre MM; Ramkumar C; Attuluri AK; Basavaraj C; Prakash C; Buturovic L; Madhav L; Naidu N; R P; Somashekhar SP; Gupta S; Doval DC; Pegram MD
Cancer Med; 2019 Apr; 8(4):1755-1764. PubMed ID: 30848103
[TBL] [Abstract] [Full Text] [Related]
2. Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer.
Stephen J; Murray G; Cameron DA; Thomas J; Kunkler IH; Jack W; Kerr GR; Piper T; Brookes CL; Rea DW; van de Velde CJ; Hasenburg A; Markopoulos C; Dirix L; Seynaeve C; Bartlett JM
Br J Cancer; 2014 Dec; 111(12):2242-7. PubMed ID: 25314051
[TBL] [Abstract] [Full Text] [Related]
3. Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer.
Rohan TE; Xue X; Lin HM; D'Alfonso TM; Ginter PS; Oktay MH; Robinson BD; Ginsberg M; Gertler FB; Glass AG; Sparano JA; Condeelis JS; Jones JG
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24895374
[TBL] [Abstract] [Full Text] [Related]
4. Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.
Madaras L; Baranyák Z; Kulka J; Szász AM; Kovács A; Lan PH; Székely B; Dank M; Nagy T; Kiss O; Harsányi L; Barbai T; Kenessey I; Tőkés AM
Pathol Oncol Res; 2013 Oct; 19(4):723-9. PubMed ID: 23709114
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancer.
Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Fu P; Honda Y; Iyama K; Iwase H
Mod Pathol; 2013 Jan; 26(1):79-86. PubMed ID: 22918168
[TBL] [Abstract] [Full Text] [Related]
